CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Current Assets
Cash and Cash Equivalents	$ 18,186,506	$ 26,555,592
Accounts Receivable, net of allowance for credit losses of $89,000 at December 31, 2024 and $1,574,000 at December 31, 2023.	1,609,718	3,827,686
Accrued Revenues in Excess of Billings	673,498	165,771
Utility Improvement Refund		208,271
Inventories, Net	4,813,226	9,000,430
Manufacturing Vendor Prepayments	372,081	403,801
Prepaid Expenses and Other Assets	1,067,461	1,338,860
Total Current Assets	26,722,490	41,500,411
Long-Term Assets
Fixed Assets, Net	7,584,284	8,072,830
Operating Lease Right-of-Use Asset	494,236	301,185
Patents and Trademarks, Net	2,998,760	2,627,018
Technology Licenses, Net	761,043	26,851,001
Cost Method Investment in Atomistic		5,784,126
Other Assets, Net	844,445	1,011,111
Total Assets	39,405,258	86,147,681
Current Liabilities
Accounts Payable	538,221	1,570,630
Unearned Revenue	125,901	18,839
Accrued Expenses	945,752	2,416,443
Licensing Fees Commitment		1,000,000
Income and Other Taxes Payable	8,163	46,727
Operating Lease Right-of-Use Liability	494,236	163,513
Total Current Liabilities	2,112,273	5,216,152
Long-Term Liabilities
Operating Lease Right-of-Use Liability		137,672
Total Liabilities	2,112,273	5,353,824
Stockholders' Equity
Common Stock - $0.001 Par Value, 100,000,000 shares authorized; 76,553,694 shares issued and 75,974,022 shares outstanding as of December 31, 2024 and 65,304,780 shares issued and 64,725,108 shares outstanding as of December 31, 2023.	76,553	65,304
Additional Paid-in Capital	407,215,883	377,189,847
Accumulated Deficit	(367,522,950)	(293,984,793)
Treasury Stock, at cost, 579,672 shares as of December 31, 2024 and 2023.	(2,476,501)	(2,476,501)
Total Stockholders' Equity	37,292,985	80,793,857
Total Liabilities and Stockholders' Equity	$ 39,405,258	$ 86,147,681